CO-WESTERN-UNION
16.3.2021 13:07:10 CET | Business Wire | Press release
The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today was named winner of the “Consumer Payments Innovation Award” in the fifth annual FinTech Breakthrough Awards for 2021. The company’s innovative cross-border money transfer solution was awarded for its ‘plug and play’ technology used by a growing number of financial institutions to offer seamless, convenient, reliable, and fast international money transfer capabilities for their customers, connecting them to more than 200 countries and territories and over 130 currencies.
Western Union’s White Label Digital Partner technology solution enables FIs to use their existing branded customer technological interface to provide international money transfer services. FI’s customers can fund the transfers drawing from their linked bank accounts, wallets, or cards and choose to pay their receivers through the world’s widest-reaching networks, operated by Western Union, accessing billions of bank accounts, millions of digital wallets, and cards, and over half a million retail locations.
The FinTech Breakthrough Awards is the premier awards program founded to recognize the FinTech innovators, leaders, and visionaries worldwide in various categories, including Digital Banking, Personal Finance, Lending, Payments, Investments, RegTech, InsurTech, and many more. The 2021 FinTech Breakthrough Award program attracted more than 3,850 nominations from across the world.
“Western Union continues to deliver stellar customer experiences for consumers and businesses, moving money around the world every day, simplifying international money transfer complexities, including compliance, regulatory control, and settlement in over 130 currencies. Western Union has taken decades of innovation in serving its own branded customers and is now offering this functionality in a breakthrough white-label arrangement, driving even more cross-border connections for the wider financial sector,” said James Johnson, Managing Director, FinTech Breakthrough.
FinTech Breakthrough Awards perform the most in-depth evaluation of the sector to recognize the creativity, hard work, and success of innovative FinTech companies, technologies, and products worldwide.
“We are thrilled with the 2021 FinTech Breakthrough Award win and are honored with the recognition for our innovative cross-border money movement ‘plug and play’ capability, offered white label or branded as a part of our Digital Partner technology solution,” said Western Union President of Global Network, Jean Claude Farah.
Farah continued, “FI customers can initiate transactions from their bank website or mobile app and send directly to beneficiaries’ bank accounts, mobile wallets, cards, or for in-person cash pickup throughout Western Union’s leading global financial network bridging more than 200 countries and territories and over 130 currencies. With our Western Union Digital Partner technology solution, FIs can count on us to handle the cross-border payout of transactions seamlessly, in minutes, at scale, and in compliance with national and international regulations.”
The opening of Western Union’s cross-border platform and global financial network to third parties marks a strategic step to evolve Western Union to a diversified payments company, accessing adjacent cross-border money movement segments, and adding incremental customers.
FIs and the customers they serve no longer need to be confined to expensive, unpredictable, traditional cross-border payment channels. Western Union’s solution keeps the customer experience firmly in the hands of the FI - from the user interface to branding to pricing - while Western Union takes care of the complexities of the cross-border payout to the beneficiary. Additionally, Western Union’s robust compliance and risk ecosystem supports partners with sanctions and interdiction screening, and real-time risk assessment to detect and prevent fraud while also meeting local regulatory requirements for payouts.
About Western Union
The Western Union Company
(NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. Western Union’s platform provides seamless cross-border flows, and its leading global financial network bridges more than 200 countries and territories and over 130 currencies. We connect businesses, financial institutions, governments, and consumers through one of the world’s widest-reaching networks, accessing billions of bank accounts, millions of digital wallets and cards, and over half a million retail locations. Western Union connects the world to bring boundless possibilities within reach. For more information, visit www.westernunion.com
.
About FinTech Breakthrough
Part of Tech Breakthrough
, a leading market intelligence and recognition platform for technology innovation and leadership around the globe, the FinTech Breakthrough Awards program is devoted to honoring excellence in Financial Technologies and Services companies and products. The FinTech Breakthrough Awards provide public recognition for the achievements of FinTech companies and products in categories including Payments, Personal Finance, Wealth Management, Fraud Protection, Banking, Lending, RegTech, InsurTech, and more. For more information, visit FinTechBreakthrough.com
.
WU-G
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005405/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
